Long-term efficacy and safety of larotrectinib in patients with TRK fusion-positive lung cancer Meeting Abstract


Authors: Lin, J. J.; Kummar, S.; Tan, D. S. W.; Lassen, U. N.; Leyvraz, S.; Liu, Y.; Moreno, V.; Patel, J. D.; Rosen, L. S.; Solomon, B. M.; Norenberg, R.; Dima, L.; Brega, N.; Shen, L.; Drilon, A. E.
Abstract Title: Long-term efficacy and safety of larotrectinib in patients with TRK fusion-positive lung cancer
Meeting Title: 2021 ASCO Annual Meeting
Journal Title: Journal of Clinical Oncology
Volume: 39
Issue: 15 Suppl.
Meeting Dates: 2021 Jun 4-8
Meeting Location: Virtual
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2021-05-20
Language: English
ACCESSION: WOS:000708120605087
DOI: 10.1200/JCO.2021.39.15_suppl.9109
PROVIDER: wos
Notes: Meeting Abstract: 9109 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Alexander Edward Drilon
    632 Drilon